This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ilves, I.
Right arrow Articles by Ustav, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ilves, I.
Right arrow Articles by Ustav, M.

 Previous Article  |  Next Article 

Journal of Virology, May 1999, p. 4404-4412, Vol. 73, No. 5
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Long-Term Episomal Maintenance of Bovine Papillomavirus Type 1 Plasmids Is Determined by Attachment to Host Chromosomes, Which Is Mediated by the Viral E2 Protein and Its Binding Sites

Ivar Ilves,1 Sirje Kivi,2 and Mart Ustav1,*

Department of Microbiology and Virology1 and Department of Cell Biology,2 Institute of Molecular and Cell Biology, Estonian Biocentre, Tartu University, 51010 Tartu, Estonia

Received 21 October 1998/Accepted 19 January 1999


    ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Papillomavirus genomes are stably maintained as extrachromosomal nuclear plasmids in dividing host cells. To address the mechanisms responsible for stable maintenance of virus, we examined nuclear compartmentalization of plasmids containing the full-length upstream regulatory region (URR) from the bovine papillomavirus type 1 (BPV1) genome. We found that these plasmids are tightly associated with the nuclear chromatin both in the stable cell lines that maintain episomal copies of the plasmids and in transiently transfected cells expressing the viral E1 and E2 proteins. Further analysis of viral factors revealed that the E2 protein in trans and its multiple binding sites in cis are both necessary and sufficient for the chromatin attachment of the plasmids. On the other hand, the BPV1 URR-dependent plasmid replication and chromatin attachment processes are clearly independent of each other. The ability of the plasmids to stably maintain episomes correlates clearly with their chromatin association function. These data suggest that viral E2 protein-mediated attachment of BPV1 genomes to the host cell chromatin could provide a mechanism for the coupling of viral genome multiplication and partitioning to the host cell cycle during viral latent infection.


    INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Precise maintenance of the cellular genome requires exact doubling of the genome once and only once during the S phase and proper partitioning of the chromosomes between the daughter cells during the M phase of the cell cycle (26). Some DNA viruses, like papillomaviruses and Epstein-Barr virus (EBV), replicate as episomal multicopy nuclear plasmids in the host cells' nuclei during a latent infection (11, 13). In order to be successfully maintained in host cells during latency, these viruses have to possess certain control mechanisms that couple multiplication of the viral genome and partitioning to the host genome maintenance cycle. The relatively small size of the papillomavirus genome puts certain limits on the use of these maintenance mechanisms. It is clear, for example, that episomal DNA viruses, unlike the cellular chromosomes, cannot afford to possess long and complex centromeric regions in their genomes that could ensure the proper partitioning and nuclear retention functions during mitosis. Therefore, some other strategy has to be used instead.

Papillomaviruses infect basal epithelial and mucosal cells in a wide range of different hosts. The infection can cause benign or malignant lesions; the most known example is common skin warts. Papillomavirus genome replication can be generally described as a three-step process (11). After entry into the basal cells, the viral genomes are quickly amplified in the host cell nucleus. Initial amplification is followed by a viral latency period, during which the viral genomes are maintained extrachromosomally at a constant copy number in the proliferating host cells. The final, vegetative amplification stage, where the formation of new infectious particles occurs, takes place only after the host cells have terminally differentiated into keratinocytes.

The process of initiation of papillomavirus DNA replication has been extensively studied, focusing mainly on bovine papillomavirus type 1 (BPV1) as a model. Only two viral proteins---E1 and E2---are required for this process, and all other necessary components are derived from the host replication machinery (5, 16, 38-40). E1 has been shown to be a viral origin recognition factor and helicase (12, 33, 41). E2, apart from being a central viral transcription regulator (9, 23), also acts as an auxiliary factor that binds to E1 and to the replication origin in a cooperative manner, thus facilitating the formation of replication initiation complex (2, 21, 24, 32, 35). The origin of papillomavirus replication has been located to the noncoding upstream regulatory region (URR). The minimal part of the URR, sufficient for the initiation of viral replication (minimal origin of replication), is composed of an A/T-rich region, binding site for E1, and one binding site for E2 (37, 39). URR sequences of different papillomaviruses contain a different number of E2 binding sites that also play an important role in viral latency. The URR of BPV1 contains 12 E2 binding sites that together form a BPV1 minichromosome maintenance element (MME). This element, in addition to the minimal origin of replication, is required for long-term episomal maintenance of BPV1 replicator in cells expressing the E1 and E2 proteins. A sufficient number of high-affinity E2 binding sites is critical for proper MME function (27). However, the function of E2 binding sites in the stable maintenance of the viral genome has been unclear until lately. Two recent publications provided the first insights, showing that BPV1 genomes, as well as E2 protein, are localized to host cell mitotic chromatin in C127 mouse fibroblasts and that mutations in E2 and E1 coding regions are able to affect such localization (18, 34).

In this study, we demonstrate that MME is likely to exert its role in episomal minichromosome maintenance of the BPV1 genome through the viral E2 protein-mediated association with the host cell nuclear chromatin. Viral E2 protein in trans and MME, comprised of multiple E2 binding sites, in cis, are both necessary and sufficient for chromatin attachment of the plasmids in our model system. On the other hand, the E1 protein or its binding site as well as the plasmid replication function can be removed without affecting the plasmid association with the chromatin. These data suggest that E2-mediated association of the viral genomes with nuclear chromatin is likely to guarantee the proper partitioning and nuclear retention of papillomavirus genomes in dividing cells as well as the optimal exposure of papillomavirus replicon to cellular replication control mechanisms during S phase. Therefore, the BPV1 stable episomal maintenance consists of two main functions---chromatin attachment, which provides proper partitioning and nuclear retention to the viral genomes, and replication function, which is responsible for compensation of the plasmid loss during host cell division.


    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Plasmid constructs. Plasmid pNeo10E2BS9 contains 10 oligomerized head-to-tail copies of high-affinity E2 binding site 9 and was constructed by inserting the BamHI-Ecl136II fragment (containing the synthetic E2 binding site oligomer) from plasmid Msp/15+10×BS9 (37) between BamHI and HpaI sites of pNeo vector. All other BPV1 URR plasmids (27) and BPV-1 E1 expression vector pCGEag (38) were described previously.

Cells and transfections. Chinese hamster ovary cell line (CHO) derivatives CHO49 (expressing BPV1 E2 protein), CHO4.15 (expressing BPV1 E1 and E2), and CHOBgl40 (CHO4.15 cells that maintain BPV-1 full-length URR plasmid pNeoBgl40 episomally) (27) were maintained in Ham's F12 medium supplemented with 10% fetal calf serum. Electroporation experiments were performed with a Bio-Rad Gene Pulser with capacitance and voltage settings of 975 µF and 230 V, respectively. The transfection efficiencies were determined by in situ staining of the cells transfected in parallel with a beta -galactosidase-expressing plasmid pON260 (38). The extraction of episomal DNA from cells and its analysis by Southern blotting were performed as described previously (38).

Cytogenetic analysis. Chromosome preparations were done by standard methods. Briefly, cells were exposed to Colcemid added at a final concentration of 0.1 µg/ml for 1 to 4 h to enrich the mitotic fraction. Colcemid-treated cells were harvested by trypsin treatment and suspended in a 0.075 M KCl solution, incubated at room temperature for 15 min, and fixed in ice-cold methanol-glacial acetic acid (3:1 [vol/vol]). The spread-out chromosomes at metaphase and nuclei at interphase for cytogenetic or fluorescence in situ hybridization analysis were prepared by dropping the cell suspension on wet slides. Chromosome analysis was performed by standard staining methods. CHO cells were karyotyped by G-banding analysis as described previously (4).

FISH. Cells were harvested and prepared for analysis as described above. Hybridization probes were generated by nick translation, using biotin-16-dUTP as a label and pNeoBgl40 plasmid as a template. The final size of probe fragments was adjusted to 100 to 300 bp by DNase I digestion in all cases. Fluorescence in situ hybridization (FISH) was performed essentially by the protocol of Tucker and coauthors (36). Briefly, chromosome preparations were denatured at 70°C in 70% formamide (pH 7.0 to 7.3) for 5 min, then immediately dehydrated in a series of washes (70, 85, and 96% ice-cold ethanol washes [for 3 min each]), and air dried. The hybridization mixture (18 µl per slide) was composed of 50% formamide in 2× SSC (1× SSC is 0.15 M NaCl plus 0.015 M sodium citrate), 10% dextran sulfate, 160 ng of a biotinylated plasmid probe DNA, and 10 µg of herring sperm carrier DNA. After 5 min of denaturation at 70°C, probe DNA was applied to each slide, sealed under a coverslip, and hybridized for 2 days at 37°C in a moist chamber. The slides were washed in three changes of 2× SSC containing 50% formamide, 2× SSC, and 2× SSC containing 0.1% IGEPAL CA-630 (Sigma Chemical Co.) at 45°C. Prior to immunofluorescence detection, slides were preincubated for 5 min in PNM buffer (PN buffer [25.2 g Na2HPO4 · 7H2O, 0.83 g NaH2PO4 · H2O, and 0.6 ml of IGEPAL CA-630 in 1 liter of H2O] with 5% nonfat dried milk and 0.02% sodium azide). After that, the probe was detected with fluorescein isothiocyanate (FITC)-conjugated extravidin. The signal was amplified with biotinylated antiavidin antibody and a second round of extravidin-FITC treatment. Between each of the steps, the slides were washed in PN buffer containing 0.05% IGEPAL CA-630 at room temperature for 15 min. Chromosomes were counterstained with propidium iodide and mounted in p-phenylenediamine antifade mounting medium. Slides were analyzed with a Olympos VANOX-S fluorescence microscope equipped with appropriate filter set. All FISH experiments were coded, and the chromosomes from at least 50 cells at metaphase and at least 200 interphase nuclei were analyzed on each slide. In addition, two slides from each sample were prepared, hybridized, and scored on different dates. Fuji Fujicolor and Agfa Agfacolor films for color prints were used for photomicrographs.


    RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

BPV1 URR-containing plasmids are associated with the host cell chromatin. It has been shown that the full-length BPV1 genomes are attached to the chromatin in C127 cells (18, 34). First we decided to examine whether the plasmids, which contain only the BPV1 URR sequences, possess the same ability in the Chinese hamster ovary (CHO) cell line-based model system, developed by us for the study of transient replication and stable maintenance of BPV1 (27, 39). We first analyzed the CHOBgl40 cell line, which expresses the BPV1 E1 and E2 proteins from integrated cassettes and maintains extrachromosomally the full-length BPV1 URR (Fig. 1) containing plasmid pNeoBgl40. A FISH analysis of both, prefixed mitotic metaphase spreads and interphase nuclei was performed with biotin-labelled BPV1 URR plasmid-specific DNA probe. The signals from hybridized probe were detected and amplified with FITC-conjugated extravidin and antiavidin antibodies, as described in Materials and Methods. The representative data are shown in Fig. 2A. The discrete yellow dots corresponding to plasmid-specific signals appeared as a merged yellow signal of the green FITC fluorescence on the red background of nuclear DNA stained with propidium iodide. The BPV1 URR plasmid signals were localized on the metaphase chromosomes with obviously random pattern distribution. Random distribution of plasmid signals was also observed in the interphase nuclei. Almost all (~90%) interphase nuclei and mitotic metaphase chromosomes from 180 analyzed cells contained BPV1 URR plasmid-specific signals, with overall number of plasmid signals from around 10 to 50 per nucleus in the majority of individual nuclei analyzed. This number is close to the estimated average of episomal plasmid copy number in CHOBgl40 cells (27), suggesting that FISH analysis was sensitive enough to detect every single plasmid copy in fixed nuclei. A small proportion of the cells from the total population contained higher number of signals (2% of cells containing more than 40 signals). However, the fractions of both high-copy-number and plasmid-negative phenotype nuclei varied significantly (up to 20% in both fractions) in several other CHOBgl40 subclones that were derived from the same long-term passage cell population. This apparent heterogeneity supports the earlier suggestion based on the similar phenotype in the case of long-term stable maintenance of full-length BPV1 genomes (28, 29, 31), that the papillomavirus partitioning and replication processes are not subjected to very strict control mechanisms.


View larger version (22K):
[in this window]
[in a new window]
 
FIG. 1.   Schematic representation and some relevant properties of the BPV1 URR constructs used in this study. The presence (+) or absence (-) of intact replication origin (replication), intact MME (sufficient number of E2 binding sites), competence for stable episomal maintenance in the long-term assay (stable maintenance), and competence of the construct for attachment to the host cell chromatin as determined by FISH analysis are indicated to the left of the schematic representations. The numbers in the schematically represented DNA sequences are the nucleotide positions in the BPV1 genome.


View larger version (40K):
[in this window]
[in a new window]
 
FIG. 2.   Multiple E2 binding sites determine the competence for chromatin attachment, but a functional replication origin is not necessary for this activity. The results of FISH analysis in the CHOBgl40 cell line that stably maintains a full-length BPV1 URR plasmid pNeoBgl40 (A) and of CHO4.15 cells transfected with plasmids (1 µg) containing different BPV1 URR inserts (B to G) that are depicted schematically in Fig. 1. Panel G shows the control experiment with plasmid containing no URR sequences E1 and E2 expression cassettes integrated into genome give cross-hybridization signals represented by double dots (indicated by arrowheads).

In addition to plasmid-specific randomly distributed single dots, two hybridization signals represented by double dots, one on both sister chromatids, were present on the spread-out chromosomes of CHOBgl40 cells. More-prominent hybridization signal on marker chromosome 8 (mar8) and much weaker signal on marker chromosome 4 (mar4) correspond to the genome-integrated E1 and E2 expression cassettes and appear as a result of cross-hybridization between bacterial plasmid backbones of the probe DNA and integrated expression cassettes. The same integrated markers were also present in the case of cell line CHO4.15, which is the BPV1 E1- and E2-expressing parental cell line used to generate the CHOBgl40 cells.

After verifying the attachment of stably maintained BPV1 URR plasmid to host mitotic chromatin, we next decided to examine whether similar attachment occurs in the case of transient-replication assay with the same plasmid. For this experiment, the BPV1 E1- and E2-expressing cell line CHO4.15 was transfected with plasmid pNeoBgl40, which contains the full-length URR of BPV1, cells were fixed 48 h after transfection, and the plasmid localization in interphase nuclei and on metaphase chromosomes was determined by FISH. Similar to the results obtained with stably maintained plasmid, randomly distributed BPV1 URR-plasmid specific signals were observed both on metaphase chromosomes and in interphase nuclei (Fig. 2B).

We conclude from these data that the BPV1 URR-containing plasmids are able to associate with host chromatin in the BPV1 E1 and E2 protein-expressing cells. The association with host chromatin is not dependent on the URR plasmid status, appearing both in the case of stably maintained and transiently replicating plasmid.

The multimerized E2 protein binding sites determine the chromatin attachment of the plasmids in the CHO4.15 cells. The data presented above showed clearly that chromatin attachment of the BPV1 URR plasmids could be studied in transient-transfection assay. A panel of different BPV1 URR-derived constructs (Fig. 1) in the same plasmid context, pNeo5', was transfected into the BPV1 E1- and E2-expressing cell line CHO4.15. Half of the cells were fixed after 48 h, and FISH analysis of the plasmid localization with specific DNA probe was performed. Low-molecular-weight DNA was extracted from the other half of the cells and analyzed by Southern blotting to estimate the overall level and replication competence of the transfected plasmid DNA in cells. FISH analysis indicated that in addition to the intact full-length URR plasmid (Bgl40) (Fig. 2B), the plasmid containing URR with disrupted E1 binding site (Xhoright-arrowHpa) also displays the localization to mitotic chromatin (Fig. 2C). The fraction of nuclei considered plasmid positive was smaller (usually 10 to 20%) than the transfection efficiencies estimated in parallel with beta -galactosidase expression plasmids (60 to 70%). These differences may be explained by different sensitivities of beta -galactosidase staining and FISH protocols. Alternatively, the lower percentage of the positive cells by FISH analysis may indicate that not all plasmid molecules that reach the nucleus after transfection will be able to attach to the chromatin or perhaps they will require longer incubation periods. For example, the successful establishment of the chromatin association may be dependent on passage of the cells through the particular cell cycle phase. One possible explanation could also be that chromatin attachment requires higher E2 levels than in some of the cells, but previous immunofluorescence analysis of the status of the E2 protein has not revealed any significant heterogeneity in the used subclones of CHO4.15 cell line (data not shown).

Plasmids with no BPV1 URR sequences (Fig. 2G) or containing essentially the minimal replication origin (Fig. 2D) with two E2 binding sites failed to give any plasmid retention in the interphase nuclei and on the metaphase chromosomes. On the other hand, parallel Southern blots indicated that the plasmid DNA was present in these cells at levels comparable to those detected in the case of plasmids that were able to localize to mitotic chromosomes (Fig. 3). For reasons that are not clear at this time, the vector molecule constantly gave lower signals upon harvesting in the transfected cells under the same transfection conditions (compare lane 13 with the other lanes with other input plasmids [Fig. 3]). DpnI cleavage also demonstrated that minimal replication origin-containing plasmid pUCAlu, despite failing to associate with mitotic chromatin, at the same time replicated efficiently in transfected cells. These data suggest the possibility that BPV1 origin-dependent replication may take place both in the chromatin-associated form, as in the case of URR-containing plasmids, and freely in the nucleoplasm, as in the case of minimal replication origin plasmid pUCAlu. The presence of CHO4.15 cell line-specific cross-hybridization signals on marker chromosomes mar4 and mar8 (see above) served as an additional internal control verifying the success of the FISH procedure.


View larger version (22K):
[in this window]
[in a new window]
 
FIG. 3.   Southern blot analysis of the extrachromosomal DNA from cells used for the parallel FISH analysis (see Fig. 2 for FISH results). Lane M contains 100 pg of linearized plasmid marker (pNeoBgl40). Lanes 1 and 2 contain extrachromosomal DNA from CHOBgl40 cells maintaining the BPV1 URR plasmid pNeoBgl40 episomally, and all the other lanes correspond to different transfections with BPV1 URR constructs (1 µg of each plasmid) in CHO4.15 cells. The mock-transfected control cells (carrier) are indicated. DNA preparations were digested with the appropriate restriction enzyme to linearize the plasmid DNA and with DpnI where indicated (+ if added, - if not) which digests only bacterially methylated DNA, thus revealing the de novo-replicated plasmid pool.

We conclude from these data that the chromosomal localization of plasmid-specific hybridization signals in the case of certain BPV1 URR constructs is not an indication of some unspecific feature of plasmid DNA but rather reflects the association with host mitotic chromatin that is dependent specifically on BPV1 URR sequences. Plasmids that are not bound to the chromatin are washed away from both the chromosome complexes at metaphase and the nuclei at interphase during fixation and hybridization procedures, as the lack of plasmid signal on metaphase chromosomes was always accompanied by the lack or very low percentage of signals in the interphase nuclei.

The failure of replicating BPV1 URR deletion construct Alu to attach to the mitotic chromosomes leads us to the conclusion that replication and chromatin attachment are separate properties of the BPV1 replicon. This conclusion is further supported by the localization of the replication-deficient construct Xhoright-arrowHpa to mitotic chromatin (Fig. 2C). On the other hand, the attachment of plasmids to chromatin was dependent on the presence of a sufficient number of high-affinity E2 binding sites in cis. As shown above, BPV1 URR constructs with intact set of 12 E2 binding sites (Bgl40 and Xhoright-arrowHpa) were able to attach to chromatin. The addition of 10 oligomerized high-affinity binding sites was able to restore the chromosome attachment activity to the construct with only two E2 binding sites (Fig. 2E). Moreover, FISH analysis demonstrated that insertion of 10 oligomerized high-affinity E2 binding sites alone into the vector was sufficient to provide the chromatin attachment activity to plasmid DNA in the absence of any other additional BPV1 URR sequences (Fig. 2F). We conclude from these data that a sufficient number of high-affinity E2 binding sites determines the plasmid association to chromosomes.

Multiple E2 binding sites in cis and viral E2 protein in trans are the viral determinants of the chromatin attachment activity of the BPV1 URR-derived plasmids. The fact that oligomerized E2 binding sites were sufficient while functional replication origin and replication ability were unnecessary for chromatin attachment made us hypothesize that the attachment occurs only if viral E2 protein were provided in cells. In order to test that, we transfected the BPV1 E2-expressing CHO49 cell line with the same plasmids. Forty-eight hours after transfection, the cells were processed further for FISH analysis to demonstrate the plasmid localization in the nuclei and for parallel Southern blotting analysis to determine the plasmid levels in cells as described above in the case of CHO4.15 cells. As shown in Fig. 4, the E2 protein alone appeared to be sufficient in trans for providing the chromatin attachment activity for URR plasmids in the host cell nuclear background. Similar to the results obtained with E1- and E2-expressing CHO4.15 cells, all constructs containing a sufficient number of E2 binding sites, Bgl40, Xhoright-arrowHpa, and D234/221+10E2BS9 (Fig. 4A, B, and C), were attached to mitotic chromosomes. Of transfected cells, 10 to 20%, depending on the transfection, were clearly positive for plasmid signals, with transfection efficiencies estimated in parallel around 50%. The percentage of positive chromosomes at metaphase was again approximately equal to the percentage of positive nuclei at interphase in analyzed individual transfections, and the plasmid-specific hybridization signals followed an apparently random pattern. Control analysis with construct that contains only two E2 binding sites did not reveal any chromosomal localization of the plasmid (Fig. 4D), even though according to the Southern blotting analysis, the plasmid DNA was present in cells in case of this and other constructs used (Fig. 5, compare lanes 1 to 8). Cross-hybridization with chromosomally integrated E2 expression cassettes (one site on two different chromosomes) served as an internal control for the success of the FISH analysis.


View larger version (68K):
[in this window]
[in a new window]
 
FIG. 4.   The chromatin attachment of URR plasmids occurs also in the absence of E1 expression; E2 protein determines the attachment activity. The results of FISH analysis in the transient assay using cell line CHO49 that expresses only BPV1 E2 protein are shown. Cells were transfected with 1 µg of plasmids containing BPV1 URR inserts depicted schematically in Fig. 1. E2 expression cassette integrated into genome gives cross-hybridization signal represented by double dots (indicated by arrowheads).


View larger version (30K):
[in this window]
[in a new window]
 
FIG. 5.   Southern blot analysis of the extrachromosomal DNA from cells used for the parallel FISH analysis (see Fig. 4 for FISH results). Lane M contains 100 pg of linearized plasmid markers (pNeoBgl40 and pNeo). Lanes 1 to 8 correspond to different transfections with BPV1 URR constructs in CHO49 cells. BPV1 E1-expressing plasmid pCGEag (250 ng) was cotransfected on the panel Bgl40+E1 (lanes 1 and 2) as a control for E2 expression (ori plasmid replicates only if both E1 and E2 proteins are present). DNA preparations were digested with the appropriate restriction enzyme to linearize the plasmid DNA and with DpnI where indicated (+ if added, - if not) which cuts only bacterially methylated DNA, thus revealing the de novo-replicated plasmid pool.

No chromatin attachment of the same plasmids was observed if the CHO cell line, which does not express any BPV1 protein, was used in a similar experiment (data not shown). We conclude from these data that E2 protein in trans and its multiple binding sites in cis are the viral determinants of the BPV1 URR-dependent chromatin attachment.

The competence of BPV1 URR plasmids for stable episomal maintenance correlates with their ability to associate with host cell chromatin. A sufficient number of E2 binding sites form the MME which together with the viral minimal replication origin provides the long-term episomal maintenance property for the BPV1 replicator (27). Because of our results indicating that MME also determines the chromosomal attachment activity for BPV1 URR, we decided to further analyze the possible connection between the stable maintenance and chromosomal attachment activities. A panel of BPV1 URR deletion constructs with known stable maintenance properties was transfected into CHO4.15 cells (Fig. 6). Cells were processed 48 h after transfection for the FISH analysis to demonstrate the chromatin attachment of plasmids (Fig. 7) and for parallel Southern blotting analysis to detect the plasmid levels in cells (Fig. 8). The results of FISH analysis demonstrated clear correlation between the competence of each plasmid for stable episomal maintenance and its ability to associate with host cell chromatin. Only constructs with functional MME (DCla/234, DCla/41, and D221/134 [Fig. 7C, D, and E]), previously shown to be capable of stable maintenance (27), were tightly associated with the mitotic chromosomes at metaphase and in the nuclei at interphase. Constructs lacking functional MME and incapable of stable replication (D221/234 and D134/234 [Fig. 7A and B]), also failed to localize to chromosomes.


View larger version (19K):
[in this window]
[in a new window]
 
FIG. 6.   Schematic representation of the structure and some relevant properties of the second panel of BPV1 URR deletion variants used in this study. See the legend to Fig. 1 for explanation of abbreviations, designations, etc.


View larger version (54K):
[in this window]
[in a new window]
 
FIG. 7.   The competence of BPV1 URR constructs for stable episomal maintenance correlates with their ability to associate with host chromatin. The results of FISH analysis in the transient assay using cell line CHO4.15 are shown. Cells were transfected with 1 µg of plasmids containing BPV1 URR inserts depicted schematically in Fig. 6. E1 and E2 expression cassettes integrated into the chromosomal DNA give cross-hybridization signals represented by double dots (indicated by arrowheads).


View larger version (27K):
[in this window]
[in a new window]
 
FIG. 8.   Southern blot analysis of the extrachromosomal DNA from cells used for the parallel FISH experiments (see Fig. 7 for FISH results). Lane M contains 100 pg of linearized plasmid markers (pNeoBgl40 and pNeo). Lanes 1 to 10 correspond to transfections with BPV1 URR constructs in CHO4.15 cells in the transient assay. DNA preparations were digested with HindIII to linearize the plasmid DNA and with DpnI (+ if added, - if not) which cuts only bacterially methylated DNA, thus revealing the de novo-replicated plasmid pool.


    DISCUSSION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Two recent articles dealing with BPV1 chromatin attachment have reviewed the results of studies of full-length viral genome DNA in mouse fibroblasts (18, 34). This system has the disadvantage of being relatively complicated, because all viral early genes, including oncogenes, are expressed from episomal viral genome in these transformed cells. Therefore, the complex interplay between E1 and different E2 transactivation and repressor forms in the processes of regulation of viral transcription, transformation, replication, and genome copy number complicates unambiguous interpretation of the involvement of different viral gene products in chromatin attachment. We have used a different approach, trying to simplify the system as much as possible, looking for the minimal viral determinants for the chromosome attachment activity. In this regard, E1- and/or E2-expressing stable cell lines serve as good model systems. These cells do not express any other papillomavirus proteins and express constant E1 and E2 levels from the integrated constructs, thus providing a more defined system for comparative studies on the behavior of different BPV1-derived constructs.

Previous studies have pointed toward the E2 protein as being the best candidate for viral trans factor required for chromatin attachment. The genetic analysis in the full-length viral genome context by Lehman and Botchan (18) has suggested that in addition to E2, the viral E1 protein seems to participate in the tethering of viral genomes to chromosomes. Our data show that E2, in the absence of E1, can be sufficient for the chromatin attachment of BPV1 URR plasmids. It is possible that E1, as well as other viral (and cellular) proteins, does contribute, indirectly or directly through interaction with the E2 protein to the attachment process. However, E2 protein clearly appears to be the central viral trans determinant for this process.

This is also the first study of the viral cis elements that determine the chromatin attachment. We show that MME, which is composed of E2 binding sites and is necessary for stable episomal maintenance of BPV1 replicon, is also necessary and sufficient for chromatin attachment activity. The experiments with BPV1 URR deletion constructs demonstrated clear correlation between the competence for stable maintenance and chromosome association. Thus, MME is likely to exert its role in the stable maintenance of BPV1 episomes by providing access to necessary cellular control mechanisms through association with host cell chromatin, presumably providing access to those cellular mechanisms that grant the partitioning and nuclear retention functions to the viral genome.

It is interesting to note that chromatin attachment occurs both in the short-term transient-transfection and long-term stable-maintenance assays. This fact supports the idea that the attachment of the viral genome to the chromatin may occur soon after sufficient levels of the E2 protein have been achieved in the cell and is not a result of the long-term selection process. It is possible that the establishment of the chromatin association is linked specifically to a certain stage of the host cell cycle as has been shown, for example, in the case of the formation of the preinitiation complex on the chromosomal replication origins. However, no experimental data are available at the moment to clarify this point. The initial viral amplification during S phase probably creates and maintains the starting population of viral genomes large enough for subsequent finding and occupying of the optimal attachment sites on the chromatin. On the other hand, the analysis of different BPV1 URR deletion constructs demonstrated clearly that the replication and chromatin attachment functions are separate E2-dependent activities of the BPV1 replicator. Thus, the plasmid replication process itself is not directly linked to the chromatin attachment process. Resulting chromatin attachment is very likely to guarantee the viral genome partitioning and nuclear retention functions during host cell division, as was suggested previously (3, 18). In addition, chromatin association can also provide the cellular replication control function to the viral origin through the optimal exposure to chromatin-associated regulatory complexes. The latter may be needed in order to avoid undesired viral overreplication and therefore can provide the copy number control mechanism for the virus during latency.

According to results of our FISH analysis, the plasmids that failed to show any attachment to metaphase chromosomes also failed to show any staining in the interphase nuclei of the transfected cells. Replication-competent plasmids that failed to give any FISH signal were capable of replicating in the same cells according to Southern blotting analysis (e.g., pNeoAlu), confirming that these plasmids had to be present in the nucleus before FISH analysis was performed. Thus, it seems most likely that plasmids which were not attached to the chromatin were simply washed away both from metaphase chromosomes and interphase nuclei during fixation and following steps of the FISH procedure. On the other hand, in the case of attachment-competent plasmids, we could not observe any considerable difference in the percentage of plasmid-specific staining if the interphase nuclei and the mitotic chromosomes at metaphase in the same transfected populations were compared. These data suggest that the MME-dependent association with host chromatin could be maintained throughout the cell cycle, including S phase. It can also be speculated that the replication of stably maintained BPV1 replicator in S phase could take place on the host chromatin, where these genomes are well exposed to the replication control mechanisms that are utilized during host genome multiplication. However, additional and more-detailed studies are necessary to examine these possibilities.

The above-proposed possible access of chromatin-attached papillomavirus genomes to chromatin-associated cellular control mechanisms cannot be sufficient to grant the viral genome with very precise replication control. It is known that the papillomavirus genome is not replicating in a strict once per cell cycle mode during the viral latency that is used by host genome but rather follows a random-choice statistical initiation mechanism (7, 27, 29). On the other hand, an example of EBV indicates that once per cell cycle replication mode can still be achieved by episomal DNA viruses (42). EBV genome plasmids and viral latent replication origin (oriP) binding protein EBNA1 are associated with the host chromosomes (8, 10), and EBNA1 is able to provide nuclear retention function to the plasmids containing multiple EBNA1 binding sites (15). It is very likely that EBNA1, similar to E2 in the case of BPV1, mediates the attachment of viral genome to chromatin. Thus, chromatin attachment as a tool to exploit cellular control mechanisms for coupling the viral partitioning and replication to the host cell genome maintenance cycle may represent a more general feature for nonlytic episomal DNA viruses. The similar functional role for DNA binding proteins and their binding sites in partitioning function has also been reported for bacterial plasmids, bacterial chromosomes (19, 20), and Saccharomyces cerevisiae plasmids (1). These data seem to point toward general evolutionary similarities in different mechanisms of partitioning of the chromosomal and extrachromosomal elements.

E2 protein appears to be necessary and sufficient for linking of the MME-containing plasmids to the chromatin. As was discussed above, E2 protein has previously been shown to be capable of associating with the chromatin (18, 34). Two previous studies have indicated that the N-terminal transcription and replication activation domain of the E2 protein is crucial for the chromatin attachment activity of the protein itself. In addition, Lehman and Botchan (18) suggest that the hinge region between N- and C-terminal domains, which includes the major phosphorylation sites of the E2 protein, is also important for the attachment. Based on these and our data, it seems reasonable to assume that both the N-terminal chromatin-bound transactivation domain and the C-terminal MME-bound DNA binding domain, serve as necessary linkers for tethering MME-containing plasmids to the host chromatin. The E2 protein binding affinity to multiple oligomeric binding sites in MME would be remarkably high due to the cooperative interaction of the bound E2 molecules with DNA (14, 25). This would provide a tightly bound proteinaceous surface formed by multiple E2 N-terminal activation domains, which is responsible for the high efficiency of the interaction with the host chromatin. Efficient multicontact interaction with chromatin might explain why this survives a relatively harsh treatment, including DNA denaturation step, during the FISH procedures. The interaction with chromatin is sufficiently strong only in the case of E2 transactivation domain, because replacing it with the respective VP16 or p53 domain inactivates the hybrid protein's ability to tether the plasmids to the chromatin in CHO and human cells (22). The chromatin binding and the DNA binding, replication, and transcription activities of the E2 protein are possibly modulated through its phosphorylation and other posttranslational modifications. This could also explain the effect of the E2 protein linker region between N- and C-terminal domains in the regulation of the chromatin binding, as the modifications in hinge region may alter the placement of the protein domains in regard to each other (18). Also, the regulation of the full-length E2 protein by its repressor forms through heterodimer formation should be considered (6, 17). Altogether it could provide a complex regulatory mechanism to control the BPV1 genome multiplication and maintenance during viral latency.

It is still hard to guess which cellular factors from the chromatin side are required for the papillomavirus genome attachment. In the case of BPV1, the minimal number of E2 binding sites sufficient to provide the minichromosome maintenance function exceeds the number of these sites generally found in upstream regulatory region of different human papillomavirus (HPV) types. Thus, in the case of the stable maintenance of the HPV genome in the transformed cells, some additional viral or cellular factors are probably necessary to provide the chromatin attachment activity. HPV URR sequences carry a so-called enhancer region, which contains numerous binding sites for different cellular transcription factors. It is tempting to speculate that certain cellular transcription activators or specific combinations of these activators, through some feature common with E2 protein, may compensate for the lack of sufficient contribution from HPV E2 binding sites. On the other hand, HPV E2 protein may provide some organizing function to these enhancer binding proteins. Interestingly, the EBNA1 protein, which is believed to be a possible mediator of the chromatin attachment of EBV genome, is also a viral transcription activator (30). It is possible that the target from the nuclear chromatin side, which allows the viral genome anchoring, may be identical in all these cases. However, the existence of such an attractive common mechanism in the case of different episomal DNA viruses remains to be proven in the future.


    ACKNOWLEDGMENTS

We thank Aare Abroi for helpful discussions throughout the course of this work, Anne Kalling for excellent technical assistance, and Kadrin Wilfong for correcting the English.

This study was supported in part by grants 2496 and 2497 from the Estonian Science Foundation, grant HHMI 75195-541301 from the Howard Hughes Medical Institute, and grants CIPA-CT94-0154 and CT96-0918 from the European Union.


    FOOTNOTES

* Corresponding author. Mailing address: Department of Microbiology and Virology, Institute of Molecular and Cell Biology, Tartu University, 23 Riia St., Tartu 51010, Estonia. Phone: 372-7-375047. Fax: 372-7-420286. E-mail: ustav{at}ebc.ee.


    REFERENCES
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

1. Ansari, A., and M. Gartenberg. 1997. The yeast silent information regulator Sir4p anchors and partitions plasmids. Mol. Cell. Biol. 17:7061-7068[Abstract].
2. Blitz, I., and L. Laimins. 1991. The 68-kilodalton E1 protein of bovine papillomavirus is a DNA binding phosphoprotein which associates with the E2 transcriptional activator in vitro. J. Virol. 65:649-656[Abstract/Free Full Text].
3. Calos, M. 1998. Stability without a centromere. Proc. Natl. Acad. Sci. USA 95:4084-4085[Free Full Text].
4. Campbell, E. W., D. Chen, J. Tesmer, R. Stallings, J. Longmire, and P. M. Kraemer. 1990. Trans-acting factors in chromosomal instability. Cancer Genet. Cytogenet. 48:89-100[Medline].
5. Chiang, C., M. Ustav, A. Stenlund, T. Ho, T. Broker, and L. Chow. 1992. Viral E1 and E2 proteins support replication of homologous and heterologous papillomaviral origins. Proc. Natl. Acad. Sci. USA 89:5799-5803[Abstract/Free Full Text].
6. Choe, J., P. Vaillancourt, A. Stenlund, and M. Botchan. 1989. Bovine papillomavirus type 1 encodes two forms of a transcriptional repressor: structural and functional analysis of new viral cDNAs. J. Virol. 63:1743-1755[Abstract/Free Full Text].
7. Gilbert, D., and S. Cohen. 1987. Bovine papilloma virus plasmids replicate randomly in mouse fibroblasts throughout S phase of the cell cycle. Cell 50:59-68[Medline].
8. Grogan, E., W. Summers, S. Dowling, D. Shedd, L. Gradoville, and G. Miller. 1983. Two Epstein-Barr viral nuclear neoantigens distinguished by gene transfer, serology, and chromosome binding. Proc. Natl. Acad. Sci. USA 80:7650-7653[Abstract/Free Full Text].
9. Ham, J., N. Dostatni, J. Gauthier, and M. Yaniv. 1991. The papillomavirus E2 protein: a factor with many talents. Trends Biochem. Sci. 16:440-444[Medline].
10. Harris, A., B. Young, and B. Griffin. 1985. Random association of Epstein-Barr virus genomes with host cell metaphase chromosomes in Burkitt's lymphoma-derived cell lines. J. Virol. 56:328-332[Abstract/Free Full Text].
11. Howley, P. M. 1996. Papillomavirinae: the viruses and their replication, p. 2045-2076. In B. C. Fields, D. M. Knipe, and P. M. Howley (ed.), Virology, 2nd ed. Lippincott-Raven Publishers, Philadelphia, Pa.
12. Hughes, F., and M. Romanos. 1993. E1 protein of human papillomavirus is a DNA helicase/ATPase. Nucleic Acids Res. 21:5817-5823[Abstract/Free Full Text].
13. Kieff, E. 1996. Epstein-Barr virus and its replication, p. 2343-2396. In B. C. Fields, D. M. Knipe, and P. M. Howley (ed.), Virology, 2nd ed. Lippincott-Raven Publishers, Philadelphia, Pa.
14. Knight, J., R. Li, and M. Botchan. 1991. The activation domain of the bovine papillomavirus E2 protein mediates association of DNA-bound dimers to form DNA loops. Proc. Natl. Acad. Sci. USA 88:3204-3208[Abstract/Free Full Text].
15. Krysan, P., S. Haase, and M. Calos. 1989. Isolation of human sequences that replicate autonomously in human cells. Mol. Cell. Biol. 9:1026-1033[Abstract/Free Full Text].
16. Kuo, S., J. Liu, T. Broker, and L. Chow. 1994. Cell-free replication of the human papillomavirus DNA with homologous viral E1 and E2 proteins and human cell extracts. J. Biol. Chem. 269:24058-24065[Abstract/Free Full Text].
17. Lambert, P., B. Spalholz, and P. Howley. 1987. A transcriptional repressor encoded by BPV-1 shares a common carboxy-terminal domain with the E2 transactivator. Cell 50:69-78[Medline].
18. Lehman, C., and M. Botchan. 1998. Segregation of viral plasmids depends on tethering to chromosomes and is regulated by phosphorylation. Proc. Natl. Acad. Sci. USA 95:4338-4343[Abstract/Free Full Text].
19. Levin, P., and A. Grossman. 1998. Cell cycle: the bacterial approach to coordination. Curr. Biol. 8:R28-R31[Medline].
20. Lin, D., and A. Grossman. 1998. Identification and characterization of a bacterial chromosome partitioning site. Cell 92:675-685[Medline].
21. Lusky, M., and E. Fontane. 1991. Formation of the complex of bovine papillomavirus E1 and E2 proteins is modulated by E2 phosphorylation and depends upon sequences within the carboxyl terminus of E1. Proc. Natl. Acad. Sci. USA 88:6363-6367[Abstract/Free Full Text].
22. Männik, A., K. Rünkorg, S. Kivi, and M. Ustav. Unpublished data.
23. McBride, A., H. Romanczuk, and P. Howley. 1991. The papillomavirus E2 regulatory proteins. J. Biol. Chem. 266:18411-18414[Free Full Text].
24. Mohr, I., R. Clark, S. Sun, E. Androphy, P. MacPherson, and M. Botchan. 1990. Targeting the E1 replication protein to the papillomavirus origin of replication by complex formation with the E2 transactivator. Science 250:1694-1699[Abstract/Free Full Text].
25. Monini, P., S. Grossman, B. Pepinsky, E. Androphy, and L. Laimins. 1991. Cooperative binding of the E2 protein of bovine papillomavirus to adjacent E2-responsive sequences. J. Virol. 65:2124-2130[Abstract/Free Full Text].
26. Nasmyth, K. 1996. Viewpoint: putting the cell cycle in order. Science 274:1643-1645[Free Full Text].
27. Piirsoo, M., E. Ustav, T. Mandel, A. Stenlund, and M. Ustav. 1996. Cis and trans requirements for stable episomal maintenance of the BPV-1 replicator. EMBO J. 15:1-11[Medline].
28. Ravnan, J., and S. Cohen. 1995. Transformed mouse cell lines that consist predominantly of cells maintaining bovine papilloma virus at high copy number. Virology 213:526-534[Medline].
29. Ravnan, J., D. Gilbert, K. Ten Hagen, and S. Cohen. 1992. Random-choice replication of extrachromosomal bovine papillomavirus (BPV) molecules in heterogeneous, clonally derived BPV-infected cell lines. J. Virol. 66:6946-6952[Abstract/Free Full Text].
30. Reisman, D., and B. Sugden. 1986. trans Activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1. Mol. Cell. Biol. 6:3838-3846[Abstract/Free Full Text].
31. Roberts, J., and H. Weintraub. 1988. Cis-acting negative control of DNA replication in eukaryotic cells. Cell 52:397-404[Medline].
32. Sedman, J., and A. Stenlund. 1995. Co-operative interaction between the initiator E1 and the transcriptional activator E2 is required for replicator specific DNA replication of bovine papillomavirus in vivo and in vitro. EMBO J. 14:6218-6228[Medline].
33. Seo, Y., F. Muller, M. Lusky, and J. Hurwitz. 1993. Bovine papilloma virus (BPV)-encoded E1 protein contains multiple activities required for BPV DNA replication. Proc. Natl. Acad. Sci. USA 90:702-706[Abstract/Free Full Text].
34. Skiadopoulos, M., and A. McBride. 1998. Bovine papillomavirus type 1 genomes and the E2 transactivator protein are closely associated with mitotic chromatin. J. Virol. 72:2079-2088[Abstract/Free Full Text].
35. Spalholz, B., A. McBride, T. Sarafi, and J. Quintero. 1993. Binding of bovine papillomavirus E1 to the origin is not sufficient for DNA replication. Virology 193:201-212[Medline].
36. Tucker, J. D., J. W. Breneman, D. A. Lee, M. J. Ramsey, and R. R. Swiger. 1994. Fluorescence in situ hybridisation of human and mouse DNA probes to determine the chromosomal contents of cell lines and tumors, p. 450-458. In J. E. Celis (ed.), Cell biology: A laboratory handbook, vol. 2. Academic Press, Inc., New York, N.Y.
37. Ustav, E., M. Ustav, P. Szymanski, and A. Stenlund. 1993. The bovine papillomavirus origin of replication requires a binding site for the E2 transcriptional activator. Proc. Natl. Acad. Sci. USA 90:898-902[Abstract/Free Full Text].
38. Ustav, M., and A. Stenlund. 1991. Transient replication of BPV-1 requires two viral polypeptides encoded by the E1 and E2 open reading frames. EMBO J. 10:449-457[Medline].
39. Ustav, M., E. Ustav, P. Szymanski, and A. Stenlund. 1991. Identification of the origin of replication of bovine papillomavirus and characterization of the viral origin recognition factor E1. EMBO J. 10:4321-4329[Medline].
40. Yang, L., R. Li, I. Mohr, R. Clark, and M. Botchan. 1991. Activation of BPV-1 replication in vitro by the transcription factor E2. Nature 353:628-632[Medline].
41. Yang, L., I. Mohr, E. Fouts, D. Lim, M. Nohaile, and M. Botchan. 1993. The E1 protein of bovine papilloma virus 1 is an ATP-dependent DNA helicase. Proc. Natl. Acad. Sci. USA 90:5086-5090[Abstract/Free Full Text].
42. Yates, J., and N. Guan. 1991. Epstein-Barr virus-derived plasmids replicate only once per cell cycle and are not amplified after entry into cells. J. Virol. 65:483-488[Abstract/Free Full Text].


Journal of Virology, May 1999, p. 4404-4412, Vol. 73, No. 5
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Feeney, K. M, Parish, J. L (2009). Targeting mitotic chromosomes: a conserved mechanism to ensure viral genome persistence. Proc R Soc B 276: 1535-1544 [Abstract] [Full Text]  
  • Jang, M. K., Kwon, D., McBride, A. A. (2009). Papillomavirus E2 Proteins and the Host Brd4 Protein Associate with Transcriptionally Active Cellular Chromatin. J. Virol. 83: 2592-2600 [Abstract] [Full Text]  
  • Poddar, A., Reed, S. C., McPhillips, M. G., Spindler, J. E., McBride, A. A. (2009). The Human Papillomavirus Type 8 E2 Tethering Protein Targets the Ribosomal DNA Loci of Host Mitotic Chromosomes. J. Virol. 83: 640-650 [Abstract] [Full Text]  
  • Lin, A., Wang, S., Nguyen, T., Shire, K., Frappier, L. (2008). The EBNA1 Protein of Epstein-Barr Virus Functionally Interacts with Brd4. J. Virol. 82: 12009-12019 [Abstract] [Full Text]  
  • Schweiger, M.-R., Ottinger, M., You, J., Howley, P. M. (2007). Brd4-Independent Transcriptional Repression Function of the Papillomavirus E2 Proteins. J. Virol. 81: 9612-9622 [Abstract] [Full Text]  
  • Kelley-Clarke, B., Ballestas, M. E., Srinivasan, V., Barbera, A. J., Komatsu, T., Harris, T.-A., Kazanjian, M., Kaye, K. M. (2007). Determination of Kaposi's Sarcoma-Associated Herpesvirus C-Terminal Latency-Associated Nuclear Antigen Residues Mediating Chromosome Association and DNA Binding. J. Virol. 81: 4348-4356 [Abstract] [Full Text]  
  • Ajay Kumar, R., Naidu, S. R., Wang, X., Imbalzano, A. N., Androphy, E. J. (2007). Interaction of Papillomavirus E2 Protein with the Brm Chromatin Remodeling Complex Leads to Enhanced Transcriptional Activation. J. Virol. 81: 2213-2220 [Abstract] [Full Text]  
  • Yu, T., Peng, Y.-C., Androphy, E. J. (2007). Mitotic Kinesin-Like Protein 2 Binds and Colocalizes with Papillomavirus E2 during Mitosis. J. Virol. 81: 1736-1745 [Abstract] [Full Text]  
  • McPhillips, M. G., Oliveira, J. G., Spindler, J. E., Mitra, R., McBride, A. A. (2006). Brd4 Is Required for E2-Mediated Transcriptional Activation but Not Genome Partitioning of All Papillomaviruses. J. Virol. 80: 9530-9543 [Abstract] [Full Text]  
  • You, J., Srinivasan, V., Denis, G. V., Harrington, W. J. Jr., Ballestas, M. E., Kaye, K. M., Howley, P. M. (2006). Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Interacts with Bromodomain Protein Brd4 on Host Mitotic Chromosomes.. J. Virol. 80: 8909-8919 [Abstract] [Full Text]  
  • Wu, S.-Y., Lee, A-Y., Hou, S. Y., Kemper, J. K., Erdjument-Bromage, H., Tempst, P., Chiang, C.-M. (2006). Brd4 links chromatin targeting to HPV transcriptional silencing. Genes Dev. 20: 2383-2396 [Abstract] [Full Text]  
  • Schweiger, M.-R., You, J., Howley, P. M. (2006). Bromodomain Protein 4 Mediates the Papillomavirus E2 Transcriptional Activation Function. J. Virol. 80: 4276-4285 [Abstract] [Full Text]  
  • Dao, L. D., Duffy, A., Van Tine, B. A., Wu, S.-Y., Chiang, C.-M., Broker, T. R., Chow, L. T. (2006). Dynamic Localization of the Human Papillomavirus Type 11 Origin Binding Protein E2 through Mitosis While in Association with the Spindle Apparatus.. J. Virol. 80: 4792-4800 [Abstract] [Full Text]  
  • Ilves, I., Maemets, K., Silla, T., Janikson, K., Ustav, M. (2006). Brd4 is involved in multiple processes of the bovine papillomavirus type 1 life cycle.. J. Virol. 80: 3660-3665 [Abstract] [Full Text]  
  • Oliveira, J. G., Colf, L. A., McBride, A. A. (2006). Variations in the association of papillomavirus E2 proteins with mitotic chromosomes. Proc. Natl. Acad. Sci. USA 103: 1047-1052 [Abstract] [Full Text]  
  • Silla, T., Haal, I., Geimanen, J., Janikson, K., Abroi, A., Ustav, E., Ustav, M. (2005). Episomal Maintenance of Plasmids with Hybrid Origins in Mouse Cells. J. Virol. 79: 15277-15288 [Abstract] [Full Text]  
  • You, J., Schweiger, M.-R., Howley, P. M. (2005). Inhibition of E2 Binding to Brd4 Enhances Viral Genome Loss and Phenotypic Reversion of Bovine Papillomavirus-Transformed Cells. J. Virol. 79: 14956-14961 [Abstract] [Full Text]  
  • Kurg, R., Sild, K., Ilves, A., Sepp, M., Ustav, M. (2005). Association of Bovine Papillomavirus E2 Protein with Nuclear Structures In Vivo. J. Virol. 79: 10528-10539 [Abstract] [Full Text]  
  • McPhillips, M. G., Ozato, K., McBride, A. A. (2005). Interaction of Bovine Papillomavirus E2 Protein with Brd4 Stabilizes Its Association with Chromatin. J. Virol. 79: 8920-8932 [Abstract] [Full Text]  
  • Baxter, M. K., McPhillips, M. G., Ozato, K., McBride, A. A. (2005). The Mitotic Chromosome Binding Activity of the Papillomavirus E2 Protein Correlates with Interaction with the Cellular Chromosomal Protein, Brd4. J. Virol. 79: 4806-4818 [Abstract] [Full Text]  
  • Brannon, A. R., Maresca, J. A., Boeke, J. D., Basrai, M. A., McBride, A. A. (2005). Reconstitution of papillomavirus E2-mediated plasmid maintenance in Saccharomyces cerevisiae by the Brd4 bromodomain protein. Proc. Natl. Acad. Sci. USA 102: 2998-3003 [Abstract] [Full Text]  
  • Zheng, P.-S., Brokaw, J., McBride, A. A. (2005). Conditional Mutations in the Mitotic Chromosome Binding Function of the Bovine Papillomavirus Type 1 E2 Protein. J. Virol. 79: 1500-1509 [Abstract] [Full Text]  
  • Srinivasan, V., Komatsu, T., Ballestas, M. E., Kaye, K. M. (2004). Definition of Sequence Requirements for Latency-Associated Nuclear Antigen 1 Binding to Kaposi's Sarcoma-Associated Herpesvirus DNA. J. Virol. 78: 14033-14038 [Abstract] [Full Text]  
  • Lim, C., Choi, C., Choe, J. (2004). Mitotic Chromosome-Binding Activity of Latency-Associated Nuclear Antigen 1 Is Required for DNA Replication from Terminal Repeat Sequence of Kaposi's Sarcoma-Associated Herpesvirus. J. Virol. 78: 7248-7256 [Abstract] [Full Text]  
  • Penrose, K. J., Garcia-Alai, M., de Prat-Gay, G., McBride, A. A. (2004). Casein Kinase II Phosphorylation-induced Conformational Switch Triggers Degradation of the Papillomavirus E2 Protein. J. Biol. Chem. 279: 22430-22439 [Abstract] [Full Text]  
  • Van Tine, B. A., Dao, L. D., Wu, S.-Y., Sonbuchner, T. M., Lin, B. Y., Zou, N., Chiang, C.-M., Broker, T. R., Chow, L. T. (2004). Human papillomavirus (HPV) origin-binding protein associates with mitotic spindles to enable viral DNA partitioning. Proc. Natl. Acad. Sci. USA 101: 4030-4035 [Abstract] [Full Text]  
  • Mechali, F., Hsu, C.-Y., Castro, A., Lorca, T., Bonne-Andrea, C. (2004). Bovine Papillomavirus Replicative Helicase E1 Is a Target of the Ubiquitin Ligase APC. J. Virol. 78: 2615-2619 [Abstract] [Full Text]  
  • Abroi, A., Ilves, I., Kivi, S., Ustav, M. (2004). Analysis of Chromatin Attachment and Partitioning Functions of Bovine Papillomavirus Type 1 E2 Protein. J. Virol. 78: 2100-2113 [Abstract] [Full Text]  
  • Barbera, A. J., Ballestas, M. E., Kaye, K. M. (2004). The Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen 1 N Terminus Is Essential for Chromosome Association, DNA Replication, and Episome Persistence. J. Virol. 78: 294-301 [Abstract] [Full Text]  
  • Deng, W., Jin, G., Lin, B.-Y., Van Tine, B. A., Broker, T. R., Chow, L. T. (2003). mRNA Splicing Regulates Human Papillomavirus Type 11 E1 Protein Production and DNA Replication. J. Virol. 77: 10213-10226 [Abstract] [Full Text]  
  • Kapoor, P., Frappier, L. (2003). EBNA1 Partitions Epstein-Barr Virus Plasmids in Yeast Cells by Attaching to Human EBNA1-Binding Protein 2 on Mitotic Chromosomes. J. Virol. 77: 6946-6956 [Abstract] [Full Text]  
  • Hou, S. Y., Wu, S.-Y., Chiang, C.-M. (2002). Transcriptional Activity among High and Low Risk Human Papillomavirus E2 Proteins Correlates with E2 DNA Binding. J. Biol. Chem. 277: 45619-45629 [Abstract] [Full Text]  
  • Jeckel, S., Huber, E., Stubenrauch, F., Iftner, T. (2002). A Transactivator Function of Cottontail Rabbit Papillomavirus E2 Is Essential for Tumor Induction in Rabbits. J. Virol. 76: 11209-11215 [Abstract] [Full Text]  
  • Malcles, M.-H., Cueille, N., Mechali, F., Coux, O., Bonne-Andrea, C. (2002). Regulation of Bovine Papillomavirus Replicative Helicase E1 by the Ubiquitin-Proteasome Pathway. J. Virol. 76: 11350-11358 [Abstract] [Full Text]  
  • Mehta, S., Yang, X. M., Chan, C. S., Dobson, M. J., Jayaram, M., Velmurugan, S. (2002). The 2 micron plasmid purloins the yeast cohesin complex: a mechanism for coupling plasmid partitioning and chromosome segregation?. JCB 158: 625-637 [Abstract] [Full Text]  
  • Boner, W., Taylor, E. R., Tsirimonaki, E., Yamane, K., Campo, M. S., Morgan, I. M. (2002). A Functional Interaction between the Human Papillomavirus 16 Transcription/Replication Factor E2 and the DNA Damage Response Protein TopBP1. J. Biol. Chem. 277: 22297-22303 [Abstract] [Full Text]  
  • Mannik, A., Runkorg, K., Jaanson, N., Ustav, M., Ustav, E. (2002). Induction of the Bovine Papillomavirus Origin "Onion Skin"-Type DNA Replication at High E1 Protein Concentrations In Vivo. J. Virol. 76: 5835-5845 [Abstract] [Full Text]  
  • Angeletti, P. C., Kim, K., Fernandes, F. J., Lambert, P. F. (2002). Stable Replication of Papillomavirus Genomes in Saccharomyces cerevisiae. J. Virol. 76: 3350-3358 [Abstract] [Full Text]  
  • Voitenleitner, C., Botchan, M. (2002). E1 Protein of Bovine Papillomavirus Type 1 Interferes with E2 Protein-Mediated Tethering of the Viral DNA to Mitotic Chromosomes. J. Virol. 76: 3440-3451 [Abstract] [Full Text]  
  • Kanda, T., Otter, M., Wahl, G. M. (2001). Coupling of Mitotic Chromosome Tethering and Replication Competence in Epstein-Barr Virus-Based Plasmids. Mol. Cell. Biol. 21: 3576-3588 [Abstract] [Full Text]  
  • Ballestas, M. E., Kaye, K. M. (2001). Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen 1 Mediates Episome Persistence through cis-Acting Terminal Repeat (TR) Sequence and Specifically Binds TR DNA. J. Virol. 75: 3250-3258 [Abstract] [Full Text]  
  • Hung, S. C., Kang, M.-S., Kieff, E. (2001). Maintenance of Epstein-Barr virus (EBV) oriP-based episomes requires EBV-encoded nuclear antigen-1 chromosome-binding domains, which can be replaced by high-mobility group-I or histone H1. Proc. Natl. Acad. Sci. USA 10.1073/pnas.031584698v1 [Abstract] [Full Text]  
  • Kanda, T, Otter, M, Wahl, G. (2001). Mitotic segregation of viral and cellular acentric extrachromosomal molecules by chromosome tethering. J. Cell Sci. 114: 49-58 [Abstract]  
  • Penrose, K. J., McBride, A. A. (2000). Proteasome-Mediated Degradation of the Papillomavirus E2-TA Protein Is Regulated by Phosphorylation and Can Modulate Viral Genome Copy Number. J. Virol. 74: 6031-6038 [Abstract] [Full Text]  
  • Velmurugan, S., Yang, X.-M., Chan, C. S.-M., Dobson, M., Jayaram, M. (2000). Partitioning of the 2-{micro}m Circle Plasmid of Saccharomyces cerevisiae: Functional Coordination with Chromosome Segregation and Plasmid-Encoded Rep Protein Distribution. JCB 149: 553-566 [Abstract] [Full Text]  
  • Zou, N., Lin, B. Y., Duan, F., Lee, K.-Y., Jin, G., Guan, R., Yao, G., Lefkowitz, E. J., Broker, T. R., Chow, L. T. (2000). The Hinge of the Human Papillomavirus Type 11 E2 Protein Contains Major Determinants for Nuclear Localization and Nuclear Matrix Association. J. Virol. 74: 3761-3770 [Abstract] [Full Text]  
  • Kurg, R., Parik, J., Juronen, E., Sedman, T., Abroi, A., Liiv, I., Langel, U., Ustav, M. (1999). Effect of Bovine Papillomavirus E2 Protein-Specific Monoclonal Antibodies on Papillomavirus DNA Replication. J. Virol. 73: 4670-4677 [Abstract] [Full Text]  
  • Fujii, T., Brandsma, J. L., Peng, X., Srimatkandada, S., Li, L., Canaan, A., Deisseroth, A. B. (2001). High and Low Levels of Cottontail Rabbit Papillomavirus E2 Protein Generate Opposite Effects on Gene Expression. J. Biol. Chem. 276: 867-874 [Abstract] [Full Text]  
  • Hung, S. C., Kang, M.-S., Kieff, E. (2001). Maintenance of Epstein-Barr virus (EBV) oriP-based episomes requires EBV-encoded nuclear antigen-1 chromosome-binding domains, which can be replaced by high-mobility group-I or histone H1. Proc. Natl. Acad. Sci. USA 98: 1865-1870 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ilves, I.
Right arrow Articles by Ustav, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ilves, I.
Right arrow Articles by Ustav, M.